Researchers at ETH Zurich in Switzerland have built tiny magnetic robots that help clot-busting medicines reach blockages deep inside blood vessels. In laboratory tests the approach dissolved clots six times faster than the drug alone, and in experiments on live pigs it restored blood flow to an area twice as large after 30 minutes.
Read more in the SingularityHub report, the ETH Zurich news article and the team's scientific preprint.
Severe blood clots can cause strokes, heart attacks and lung embolisms. Doctors treat them with drugs such as tPA, short for tissue plasminogen activator, a protein that breaks clots down, delivered through a thin tube called a catheter. But when a blockage stops the blood flow, the drug can only inch forward by diffusion, the slow drifting of molecules through still fluid, so treatment loses precious time.
Rolling robots that stir the blood
The new robots, called HydroBots, are about eight micrometers long, roughly the size of red blood cells. Each is a grain-shaped bead of biocompatible sugar-based gel filled with magnetic iron oxide nanoparticles, pulled into a line during manufacturing so the bead acts like a tiny compass needle. A magnetic control system outside the body then makes the robots tumble end over end along the vessel wall, like a gymnast doing handsprings. The robots carry no medicine themselves. Released near a clot together with the drug, their rolling stirs the stagnant blood and creates currents that push the medicine into the blockage.
The team tested the idea in a silicon model of blood vessels plugged with clots made from pig blood. Working with researchers at Charité University Hospital in Berlin, they also blocked arteries in live pigs. Group leader Simone Schürle says it is the first time microrobots have been shown to enhance thrombolysis, the medical term for dissolving clots, in a clinically relevant large animal.
If the results hold up, the method could help existing drugs work faster and at lower doses. That matters because high doses of clot-busting medicine raise the risk of dangerous bleeding, and because strokes and heart attacks are emergencies where every minute of blocked blood flow causes more damage.
The work is still early. The paper has not yet finished peer review, human trials are far off, and longer animal safety studies are planned. ETH Zurich has filed a patent application for the robots.